254 related articles for article (PubMed ID: 20632576)
1. Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithms.
Rivard MJ; Beaulieu L; Mourtada F
Med Phys; 2010 Jun; 37(6):2645-58. PubMed ID: 20632576
[TBL] [Abstract][Full Text] [Related]
2. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation.
Beaulieu L; Carlsson Tedgren A; Carrier JF; Davis SD; Mourtada F; Rivard MJ; Thomson RM; Verhaegen F; Wareing TA; Williamson JF
Med Phys; 2012 Oct; 39(10):6208-36. PubMed ID: 23039658
[TBL] [Abstract][Full Text] [Related]
3. AAPM WGDCAB Report 372: A joint AAPM, ESTRO, ABG, and ABS report on commissioning of model-based dose calculation algorithms in brachytherapy.
Beaulieu L; Ballester F; Granero D; Tedgren ÅC; Haworth A; Lowenstein JR; Ma Y; Mourtada F; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Fonseca G; Vijande J
Med Phys; 2023 Aug; 50(8):e946-e960. PubMed ID: 37427750
[TBL] [Abstract][Full Text] [Related]
4. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
[TBL] [Abstract][Full Text] [Related]
5. A user-oriented procedure for the commissioning and quality assurance testing of treatment planning system dosimetry in high-dose-rate brachytherapy.
Peppa V; Pantelis E; Pappas E; Lahanas V; Loukas C; Papagiannis P
Brachytherapy; 2016; 15(2):252-62. PubMed ID: 26727331
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
7. The evolution of brachytherapy treatment planning.
Rivard MJ; Venselaar JL; Beaulieu L
Med Phys; 2009 Jun; 36(6):2136-53. PubMed ID: 19610303
[TBL] [Abstract][Full Text] [Related]
8. Breaking bad IMRT QA practice.
Stojadinovic S; Ouyang L; Gu X; Pompoš A; Bao Q; Solberg TD
J Appl Clin Med Phys; 2015 May; 16(3):5242. PubMed ID: 26103484
[TBL] [Abstract][Full Text] [Related]
9. A review of dosimetric impact of implementation of model-based dose calculation algorithms (MBDCAs) for HDR brachytherapy.
Yousif YAM; Osman AFI; Halato MA
Phys Eng Sci Med; 2021 Sep; 44(3):871-886. PubMed ID: 34142317
[TBL] [Abstract][Full Text] [Related]
10. A MC-based anthropomorphic test case for commissioning model-based dose calculation in interstitial breast 192-Ir HDR brachytherapy.
Peppa V; Thomson RM; Enger SA; Fonseca GP; Lee C; Lucero JNE; Mourtada F; Siebert FA; Vijande J; Papagiannis P
Med Phys; 2023 Jul; 50(7):4675-4687. PubMed ID: 37194638
[TBL] [Abstract][Full Text] [Related]
11. AAPM TG-43 formalism for brachytherapy dose calculation of a 137Cs tube source.
Zhang P; Beddar AS; Sibata CH
Med Phys; 2004 Apr; 31(4):755-9. PubMed ID: 15124992
[TBL] [Abstract][Full Text] [Related]
12. Brachytherapy dosimetry parameters calculated for a new 103Pd source.
Rivard MJ; Melhus CS; Kirk BL
Med Phys; 2004 Sep; 31(9):2466-70. PubMed ID: 15487726
[TBL] [Abstract][Full Text] [Related]
13. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
[TBL] [Abstract][Full Text] [Related]
14. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
Williamson JF; Butler W; Dewerd LA; Huq MS; Ibbott GS; Mitch MG; Nath R; Rivard MJ; Todor D;
Med Phys; 2005 May; 32(5):1424-39. PubMed ID: 15984693
[TBL] [Abstract][Full Text] [Related]
15. Brachytherapy source characterization for improved dose calculations using primary and scatter dose separation.
Russell KR; Tedgren AK; Ahnesjö A
Med Phys; 2005 Sep; 32(9):2739-52. PubMed ID: 16266087
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of TG-43 recommended 2D-anisotropy function for elongated brachytherapy sources.
Awan SB; Meigooni AS; Mokhberiosgouei R; Hussain M
Med Phys; 2006 Nov; 33(11):4271-9. PubMed ID: 17153405
[TBL] [Abstract][Full Text] [Related]
17. AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron Beams.
J Appl Clin Med Phys; 2016 Jan; 17(1):457. PubMed ID: 26894369
[No Abstract] [Full Text] [Related]
18. Model-Based Dose Calculation Algorithms for Brachytherapy Dosimetry.
Enger SA; Vijande J; Rivard MJ
Semin Radiat Oncol; 2020 Jan; 30(1):77-86. PubMed ID: 31727303
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric characteristics of a linear array of gamma or beta-emitting seeds in intravascular irradiation: Monte Carlo studies for the AAPM TG-43/60 formalism.
Ye SJ; Parsai EI; Feldmeier JJ
Med Phys; 2003 Mar; 30(3):403-14. PubMed ID: 12674241
[TBL] [Abstract][Full Text] [Related]
20. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
Poon E; Verhaegen F
Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
